Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Why do schizophrenic patients refuse to take their drugs?

Van Putten T.

Arch Gen Psychiatry. 1974 Jul;31(1):67-72. No abstract available.

PMID:
4151750
2.

[Extrapyramidal movement disorders arising during treatment of psychoses with drugs].

Vatsek Ia.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1976;76(3):453-7. Review. Russian. No abstract available.

PMID:
4940
3.

The management of schizophrenia.

Bennett DH.

Br J Psychiatry. 1975;Spec No 9:48-54. Review. No abstract available.

PMID:
241452
4.

Suicide in schizophrenia: risk factors and clozapine treatment.

Meltzer HY.

J Clin Psychiatry. 1998;59 Suppl 3:15-20. Review.

PMID:
9541333
5.
6.

Drug-induced extrapyramidal syndromes.

Lader MH.

J R Coll Physicians Lond. 1970 Oct;5(1):87-98. Review. No abstract available.

PMID:
4150143
7.

Psychoeducation as an indispensable complement to pharmacotherapy in schizophrenia.

Motlová L.

Pharmacopsychiatry. 2000 Sep;33 Suppl 1:47-8. Review.

PMID:
11072765
8.

Use of novel antipsychotic drugs.

Raleigh F.

Pharmacotherapy. 1996 Nov-Dec;16(6 Pt 2):160S-165S; discussion 166S-168S. Review.

PMID:
8948000
9.

The clinical use of antipsychotic medications.

Coyle JT.

Med Clin North Am. 1982 Sep;66(5):993-1009. Review. No abstract available.

PMID:
6127455
10.

Pathophysiology of antipsychotic drug-induced movement disorders.

Casey DE.

J Clin Psychiatry. 2004;65 Suppl 9:25-8. Review.

PMID:
15189109
11.

[On application of antipsychotic drugs].

Shimizu M.

No To Shinkei. 1994 Mar;46(3):209-14. Review. Japanese. No abstract available.

PMID:
7910750
12.

Partial response to antipsychotic treatment: the patient with enduring symptoms.

Emsley RA.

J Clin Psychiatry. 1999;60 Suppl 23:10-3. Review.

PMID:
10625194
13.

Assessment of anti-psychotic drugs.

Mackay AV.

Br J Clin Pharmacol. 1981 Mar;11(3):225-36. Review. No abstract available.

14.

The older patient: the ongoing challenge of efficacy and tolerability.

Tariot PN.

J Clin Psychiatry. 1999;60 Suppl 23:29-33. Review.

PMID:
10625198
15.

Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?

Hawkins KA, Mohamed S, Woods SW.

Psychol Med. 1999 Jan;29(1):1-8. Review. No abstract available.

PMID:
10077288
16.

Some adverse effects of antipsychotics: prevention and treatment.

Lader M.

J Clin Psychiatry. 1999;60 Suppl 12:18-21. Review.

PMID:
10372605
17.

Rational use of psychotropic drugs. III. Major tranquilizers.

Greenblatt DJ, Shader RI.

Am J Hosp Pharm. 1974 Dec;31(12):1226-31. Review. No abstract available.

PMID:
4156455
18.

Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report.

Kane JM, Dauphinais D, Barnes TR, Adler LA, Rifkin A.

Psychopharmacol Bull. 1993;29(1):45-9. Review. No abstract available.

PMID:
8104351
19.
20.

Maintenance antipsychotic therapy: is the cure worse than the disease?

Gardos G, Cole JO.

Am J Psychiatry. 1976 Jan;133(1):32-6. Review.

PMID:
2021
Items per page

Supplemental Content

Write to the Help Desk